导师类型：硕士生导师
单 位：02广安门医院
出生年月：1987年06月
专业职务：副主任医师
学 位：医学博士
毕业学校：北京中医药大学
第一学科：中医学
第二学科：中医内科学
研究方向：糖尿病及其并发症的中医药防治
联系电话：18810383272
邮 箱：tina_yai@126.com
邮 编：100053
联系地址：北京市西城区北线阁5号中国中医科学院广安门医院
个人简介：田佳星，医学博士，副主任医师，入选中国科协青年托举人才、中国中医科学院优秀青年科技人才、中国中医科学院广安门医院续航工程——青年拔尖人才、国家中医药多学科交叉创新团队创新人才培养对象，硕博师从中国科学院院士仝小林教授，主要从事糖尿病及其并发症临床与基础研究。主持国家自然科学基金、首都卫生发展科研专项、中国中医科学院科创工程、中国中医科学院优青培养专项等课题8项，参与国家级及省部级课题10余项。在[i]Pharmacol Res、Cell Death and Disease、Diabetes Obes Metab、Comput Struct Biotechnol J [/i]《中医杂志》《中国中西医结合杂志》《中华中医药杂志》《中国糖尿病杂志》等期刊发表学术论文92篇，其中SCI论文42篇；在[i]The Lancet Diabetes & Endocrinology、Diabetes[/i]发表摘要3篇；主研执笔1项临床试验研究入选2021高被引论文，进入[i]Pharmacology & Toxicology[/i]学术领域最优秀1%之列。参编《糖尿病并发症中医诊疗学》《糖尿病中医药临床循证实践指南》《中国中医药重大理论传承创新典藏》等著作8部；作为主要完成人获中国中西医结合学会科技进步一等奖，世界中医药学会联合会科技进步一等奖、中华中医药学会科学技术二等奖，研究成果入选中华中医药学会“中医药优秀青年学者科技成果”，获国内外学术会议最佳壁报奖2次。兼任中国中医药研究促进会糖尿病专业委员会副秘书长、中华中医药学会青年委员会委员等。在临床研究方面，前期作为课题骨干参与项目组糖尿病多中心临床试验研究，通过高级别循证医学证据证实中医药降低血糖、保护胰岛功能、改善多代谢紊乱的作用。在糖尿病并发症研究中，通过多中心临床试验及病历数据总结，证实中医药具有延缓和改善糖尿病视网膜病变、糖尿病肾病、糖尿病胃肠病变疾病进展的作用。在基础研究方面，从事多项糖尿病机制探索工作，证实中药改善糖尿病模型动物“血糖代谢-调节肠道微生态-保护肠黏膜屏障-抑制炎症”作用，目前重点围绕多组学技术探索中医药调控多代谢紊乱的疗效机制。
论文：
过食肥甘与糖尿病关系的历史沿革 中医杂志 2018/6/1
肠道微生态与2型糖尿病关系的研究进展 中国糖尿病杂志 2018/8/1
基于肠道微生态探讨小檗碱改善代谢紊乱的作用机制 中国中西医结合杂志 2020/1/1
破血逐瘀通络治法的临床应用概况 中成药 2021/9/1
现代组学技术在中医证候研究的进展 中华中医药学刊 2023/2/1
Efficacy of Chinese herbal medicine compared with metformin for glucose regulation and cardiovascular risk factors in patients with type 2 diabetes with dyslipidaemia (Abstract) The Lancet Diabetes & Endocrinology 2016/11/1
Safety and effectiveness of different herbal medicine dosage of Gegen Qinlian Decoction in patients with T2DM (Abstract) The Lancet Diabetes & Endocrinology 2016/11/1
Alleviation Effects of a TCM on Diabetes in Rats Linked to Modulation of the Gut Microbiome (Abstract) Diabetes 2019/6/1
Evidence and Potential Mechanisms of Traditional Chinese Medicine for the Treatment of Type 2 Diabetes: A Systematic Review and Meta-analysis Diabetes Obes Metab 2019/8/1
Hanshiyi Formula, a medicine for Sars-CoV2 infection in China, reduced the proportion of mild and moderate COVID-19 patients turning to severe status: A cohort study Pharmacol Res 2020/11/1
Therapeutic mechanisms of traditional Chinese medicine to improve metabolic diseases via the gut microbiota Biomed Pharmacother 2021/1/1
The Influence of Different Types of Diabetes on Vascular Complications J Diabetes Res 2022/2/1
Akt: A Potential Drug Target for Metabolic Syndrome Front Physiol 2022/3/1
Research progress on the pharmacological effects of berberine targeting mitochondria Front Endocrinol (Lausanne) 2022/8/1
Metformin modulates the gut microbiome in a mice model of high-fat diet-induced glycolipid metabolism disorder BMJ Open Diabetes Res Care 2022/12/1
PDX-1: A Promising Therapeutic Target to Reverse Diabetes Biomolecules 2022/11/1
Advances in multi-omics study of biomarkers of glycolipid metabolism disorder Computational and Structural Biotechnology Journal 2022/10/1
Iron metabolism and ferroptosis in type 2 diabetes mellitus and complications: mechanisms and therapeutic opportunities Cell Death & Disease 2023/3/8
专著：
白脉软膏治疗糖尿病周围神经病变的临床应用 中国临床药理学杂志
重大新发突发公共卫生事件中医药社区防控创新实践 上海科学技术出版社
天芪降糖胶囊延缓糖尿病发生的临床及机理研究 中国中西医结合学会科技进步奖
以津力达颗粒为示范的中西药联合应用的规范化研究 中华中医药学会科学技术奖
获奖：
过食肥甘与糖尿病关系的历史沿革 中医杂志
肠道微生态与2型糖尿病关系的研究进展 中国糖尿病杂志
基于肠道微生态探讨小檗碱改善代谢紊乱的作用机制 中国中西医结合杂志
破血逐瘀通络治法的临床应用概况 中成药
现代组学技术在中医证候研究的进展 中华中医药学刊
Efficacy of Chinese herbal medicine compared with metformin for glucose regulation and cardiovascular risk factors in patients with type 2 diabetes with dyslipidaemia (Abstract) The Lancet Diabetes & Endocrinology
Safety and effectiveness of different herbal medicine dosage of Gegen Qinlian Decoction in patients with T2DM (Abstract) The Lancet Diabetes & Endocrinology
Alleviation Effects of a TCM on Diabetes in Rats Linked to Modulation of the Gut Microbiome (Abstract) Diabetes
Evidence and Potential Mechanisms of Traditional Chinese Medicine for the Treatment of Type 2 Diabetes: A Systematic Review and Meta-analysis Diabetes Obes Metab
Hanshiyi Formula, a medicine for Sars-CoV2 infection in China, reduced the proportion of mild and moderate COVID-19 patients turning to severe status: A cohort study Pharmacol Res
Therapeutic mechanisms of traditional Chinese medicine to improve metabolic diseases via the gut microbiota Biomed Pharmacother
The Influence of Different Types of Diabetes on Vascular Complications J Diabetes Res
Akt: A Potential Drug Target for Metabolic Syndrome Front Physiol
Research progress on the pharmacological effects of berberine targeting mitochondria Front Endocrinol (Lausanne)
Metformin modulates the gut microbiome in a mice model of high-fat diet-induced glycolipid metabolism disorder BMJ Open Diabetes Res Care
PDX-1: A Promising Therapeutic Target to Reverse Diabetes Biomolecules
Advances in multi-omics study of biomarkers of glycolipid metabolism disorder Computational and Structural Biotechnology Journal
Iron metabolism and ferroptosis in type 2 diabetes mellitus and complications: mechanisms and therapeutic opportunities Cell Death & Disease
